Yearly Archives - 2018

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services ("CMS") has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have CMS establish two new Level II HCPCS codes to describe “microprocessor-controlled, custom fabricated upper extremity braces. Read more >>
Read more...

Shiva Kashalkar: Integrating Passion and Business to Create “Netflix” for Toys

When Shiva Kashalkar’s daughter was eight months old, she realized that she was paying several hundred dollars every month for toys that she would only play with for a few days. The clutter from unused toys drove her crazy. Talking with other parents, she learned this was a common issue and became inspired to start Green Piñata Toys. Read more >>
Read more...

The Pros from Dover

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. Jack of all spades. Master of none. Sometimes an enterprise — whether a startup or a multinational — can’t or shouldn’t try to do everything. Product design for example. If a company’s forte is ... say ... farm equipment, it ought think twice before getting...
Read more...

And Now … A Word from an Entrepreneur

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. A prior guest of the podcast likened markets to conversations. The entrepreneur introduces a product. The buying community accepts or rejects it. The entrepreneur tweaks and reintroduces the product. With luck, the buying community accepts it with more gusto. This back and forth, a conversation of sorts, continues until...
Read more...

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
Read more...

Platelet BioGenesis Licenses Induced Pluripotent Stem Cell Technology from iPS Academia Japan

Platelet BioGenesis, a pioneer in the production of functional human platelets (PLTs+™) from stem cells, announced it has licensed patents related to induced pluripotent stem cells (“iPS cells”) from iPS Academia Japan’s patent portfolio. This non-exclusive agreement moves Platelet BioGenesis closer to its goal of producing functional human platelets at commercial scale. Read more >>
Read more...